Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin
Jiro Inagaki
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Search for more papers by this authorYoshihisa Nagatoshi
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Search for more papers by this authorYoshifumi Kawano
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima
Search for more papers by this authorYusuke Saito
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Search for more papers by this authorDaijiro Takahashi
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Search for more papers by this authorJun Nagayama
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Search for more papers by this authorYuichi Shinkoda
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Search for more papers by this authorHideki Hirata
Section of Radiology, National Kyusyu Cancer Center
Search for more papers by this authorJun Okamura
Institute for Clinical Research, National Kyusyu Cancer Center, Fukuoka, Japan
Search for more papers by this authorJiro Inagaki
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Search for more papers by this authorYoshihisa Nagatoshi
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Search for more papers by this authorYoshifumi Kawano
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima
Search for more papers by this authorYusuke Saito
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Search for more papers by this authorDaijiro Takahashi
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Search for more papers by this authorJun Nagayama
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Search for more papers by this authorYuichi Shinkoda
Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka
Search for more papers by this authorHideki Hirata
Section of Radiology, National Kyusyu Cancer Center
Search for more papers by this authorJun Okamura
Institute for Clinical Research, National Kyusyu Cancer Center, Fukuoka, Japan
Search for more papers by this authorAbstract
Abstract: We have employed the 3 Gy toal body irradiation (TBI) containing conditioning regimen to bone marrow transplantation (BMT) for severe aplastic anemia (SAA) in pediatric patients irrespective of donor type since March 1986. The outcome of BMT for 17 SAA patients is favorable. Eight patients received BMT from human leukocyte antigen matched-related donors (MRD) and nine received BMT from alternative donors. The conditioning regimen consisted of 3-Gy TBI and cyclophosphamide of 200 mg/kg in the BMT from MRD. In the case of BMT from alternative donor, antithymocyte globulin 10 mg/kg was added to the regimen. Fifteen of 17 patients (88%) engrafted on median of day 18 (range, 11–26) and all 13 evaluable patients showed complete donor chimerism by median 30 (range, 13–47) days after BMT. Fourteen patients have survived with a median follow-up of 67 (range, 2–228) months and the probability of survival was 81.9% (95% CI, 63.3–100%). No late complications including second malignancies caused by TBI have been observed and all three female patients have regular menstruation. In conclusion, TBI of 3 Gy appears to be an appropriate dose regarding to ensure engraftment and avoid the risk of late adverse event for SAA patients.
References
- 1 Kahl C, Leisenring W, Deeg HJ, et al. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: A long-term follow-up. Br J Haematol 2005: 130: 747–751.
- 2 Kojima S, Horibe K, Inaba J, et al. Long-term outcome of acquired aplastic anemia in children; comparison between immunosuppressive therapy and bone marrow transplantation. Br J Haematol 2000: 111: 321–328.
- 3 Kojima S, Kobayashi R, Yabe H, et al. High incidence of graft rejection in children with severe aplastic anemia preconditioned with cyclophosphamide and antithymocyte globulin regimen. Blood 2001: 98 (Suppl.): 376b.
- 4 Davies SM, Wagner JE, Defor T, et al. Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia. Br J Haematol 1997: 96: 749–756.
- 5 Hows JM, Yin JL, Marsh J, et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986: 68: 1322–1328.
- 6 Camitta B, Ash R, Menitove J, et al. Bone marrow transplantation for children with severe aplastic anemia: Use of donors other than HLA-identical siblings. Blood 1989: 74: 1852–1857.
- 7 Champlin RE, Horowitz MM, Van Bekkum DW, et al. Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results. Blood 1989: 73: 606–613.
- 8 Kojima S, Matsuyama T, Kato S, et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: The Japan Marrow Donor Program. Blood 2002: 100: 799–803.
- 9
Deeg HJ,
Seidel K,
Casper J, et al.
Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.
Biol Blood Marrow Transplant
1999: 54: 243–252.
10.1053/bbmt.1999.v5.pm10465104 Google Scholar
- 10 Petersdrf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998: 92: 3515–3520.
- 11 Kojima S, Inaba J, Yoshimi A, et al. Unrelated donor marrow transplantation in children with severe aplastic anaemia using cyclophosphamide, anti-thymocyte globulin and total body irradiation. Br J Haematol 2001: 114: 706–711.
- 12 Vassiliou GS, Webb DK, Pamphilon D, Knapper S, Veys PA. Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath. Br J Haematol 2001: 114: 701–705.
- 13 Crawford SW, Longton G, Storb R. Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 1993: 12: 225–231.
- 14 Clement-De Boers A, Oostdiik W, Van Weel-Sipman MH, et al. Final height and hormonal function after bone marrow transplantation in children. J Pediatr 1996: 129: 544–550.
- 15 Deeg HJ, Leisenring W, Storb R, et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 1998: 91: 3637–3645.
- 16 Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997: 336: 897–904.
- 17 Pierga JY, Socie G, Gluckman E, et al. Secondary solid malignant tumors occurring after bone marrow transplantation for severe aplastic anemia given thoraco-abdominal irradiation. Radiother Oncol 1994: 30: 55–58.
- 18 Socie G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med 1993: 329: 1152–1157.
- 19 Deeg HJ, Socie G, Schoch M, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients. Blood 1996: 87: 386–392.
- 20 Thomas ED, Storb R, Fefer A, et al. Aplastic anemia treated by marrow transplantation. Lancet 1972: 1: 284–289.
- 21 Storb R, Thomas ED, Weiden PL, et al. Aplastic anemia treated by allogeneic bone marrow transplantation: A report of 49 new cases from Seattle. Blood 1976: 48: 817–841.
- 22 Storb R, Rudolph RH, Graham TC, Thomas ED. The influence of transfusions from unrelated donors upon marrow grafts between histocompatible canine siblings. J Immunol 1971: 107: 409–413.
- 23 Storb R, Thomas ED, Buckner CD, et al. Marrow transplantation in thirty ‘‘untransfused’’ with severe aplastic anemia. Ann Intern Med 1980: 92: 30–36.
- 24 Storb R, Etzioni R, Anasetti C, et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994: 84: 941–949.
- 25 Parkman R, Rappeport J, Camitta B, Levey RH, Nathan DG. Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients. Blood 1978: 52: 1163–1169.
- 26 Ramsay NK, Kim T, Nesbit ME, et al. Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation for severe aplastic anemia. Blood 1980: 55: 344–346.
- 27 Feig SA, Champlin R, Arenson E, et al. Improved survival following bone marrow transplantation for aplastic anemia. Br J Haematol 1983: 54: 509–517.
- 28 Gale RP, Ho W, Feig S, et al. Prevention of graft rejection following bone marrow transplantation. Blood 1981: 57: 9–12.
- 29 Storb R, Prentice RL, Thomas ED. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med 1977: 296: 61–66.
- 30 Storb R, Doney KC, Thomas ED, et al. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 1982: 59: 236–246.
- 31 Storb R, Blume KG, O'Donnell MR, et al. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centers. Biol Blood Marrow Transplant 2001: 7: 39–44.
- 32 Deeg HJ, Anasetti C, Petersdorf E, et al. Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A,B,DRB matched unrelated donors. Blood 1994: 83: 3417–3418
- 33 Wagner JL, Deeg HJ, Seidel K, et al. Bone marrow transplantation for severe aplastic anemia from genotypically HLA-non-identical relatives. An update of the Seattle experience. Transplantation 1996: 61: 54–61.
- 34 Appelbaum FR. The influence of total dose, fractionation, dose rate and distribution of total body irradiation on bone marrow transplantation. Semin Oncol 1993: 20: 3–10.
- 35 Deeg HJ, Amylon MD, Harris RE, et al. Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation. Biol Blood Marrow Transplant 2001: 7: 208–215.
- 36 Deeg HJ, O'Donnell M, Tolar J, et al. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 2006: 108: 1485–1491.
- 37 Bacigalupo A, Locatelli F, Lanino E, et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: A report from the EBMT-SAA Working Party. Bone Marrow Transplant 2005: 36: 947–950.
- 38 Margolis D, Camitta B, Pietryga D, et al. Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. Br J Haematol 1996: 94: 65–72.
- 39 Lee JH, Choi SJ, Lee JH, et al. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 2005: 35: 755–761.
- 40 Kang HJ, Shin HY, Choi HS, Ahn HS. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. Bone Marrow Transplant 2004: 34: 939–943.
- 41 Gupta V, Ball SE, Sage D, et al. Marrow transplants from matched unrelated donors for aplastic anemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant 2005: 35: 467–471.
- 42 Anasetti C, Petersdorf EW, Martin PJ, Woolfrey A, Hansen JA. Improving availability and safety of unrelated donor transplants. Curr Opin Oncol 2000: 12: 121–126.
- 43 Sanders JE, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996: 87: 3045–3052.
- 44 Jacob A, Barker H, Goodman A, Holmes J. Recovery of spermatogenesis following bone marrow transplantation. Bone Marrow Transplant 1998: 22: 277–279.
- 45 Jacob A, Goodman A, Holmes J. Fertility after bone marrow transplantation following conditioning with cyclophosphamide and total body irradiation. Bone Marrow Transplant 1995: 15: 483–484.
- 46 Matsumoto M, Shinohara O, Ishiguro H, et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child 1999: 80: 452–454.